Abstract
Novel representatives of phosphoryl guanidine oligonucleotide derivatives were prepared in this study. A synthetic scheme has been proposed and implemented suitable for the preparation of a wide range of diaminocarbenium azides starting from various secondary amines for subsequent incorporation of tetrasubstituted guanidine residues into the oligonucleotides by the Staudinger reaction. A number of factors which affected the yield of the phosphoryl guanidine derivative were identified, in particular, the size of the alkyl substituents in the azide used, the purity of the azide, and the conditions for elimination of the protecting cyanoethyl group before the final deprotection of the oligonucleotide.
Similar content being viewed by others
REFERENCES
Yin, W. and Rogge, M., Clin. Transl. Sci., 2019, vol. 12, pp. 98–112. https://doi.org/10.1111/cts.12624
Heo, Y.A., Drugs, 2020, vol. 80, pp. 329–333. https://doi.org/10.1007/s40265-020-01267-2
Balwani, M., Sardh, E., Ventura, P., Peiro, P.A., Rees, D.C., Stolzel, U., Bissell, D.M., Bonkovsky, H.L., Windyga, J., Anderso, K.E., Parker, C., Silver, S.M., Keel, S.B., Wang, J.D., Stein, P.E., Harper, P., Vassiliou, D., Wang, B., Phillips, J., Ivanova, A., Langendonk, J.G., Kauppinen, R., Minder, E., Horie, Y., Penz, C., Chen, J.H., Liu, S.B., Ko, J.J., Sweetser, M.T., Garg, P., Vaishnaw, A., Kim, J.B., Simon, A.R., Gouya, L., and Investigators, E., N. Engl. J. Med., 2020, vol. 382, pp. 2289–2301. https://doi.org/10.1056/NEJMoa1913147
Rinaldi, C. and Wood, M.J.A., Nat. Rev. Neurol., 2018, vol. 14, pp. 9–21. https://doi.org/10.1038/nrneurol.2017.148
Deleavey, G.F. and Damha, M.J., Chem. Biol., 2012, vol. 19, pp. 937–954. https://doi.org/10.1016/j.chembiol.2012.07.011
Roy, S. and Caruthers, M., Molecules, 2013, vol. 18, pp. 14268–14284. https://doi.org/10.3390/molecules181114268
Kupryushkin, M.S., Pyshnyi, D.V., and Stetsenko, D.A., Acta Naturae, 2014, vol. 6, pp. 116–118. https://doi.org/10.32607/20758251-2014-6-4-116-118
Dyudeeva, E.S., Kupryushkin, M.S., Lomzov, A.A., Pyshnaya, I.A., and Pyshnyi, D.V., Russ. J. Bioorg. Chem., 2019, vol. 45, pp. 709–718. https://doi.org/10.1134/S1068162019060153
Stetsenko, D., Kupryshkin, M., and Pyshnyi, D., WO Patent no. WO2016028187A1, 2016.
Wieland, G. and Simchen, G., Liebigs Ann. Chem., 1985, vol. 1985, pp. 2178–2193. https://doi.org/10.1002/jlac.198519851108
Kitamura, M. and Murakami, K., Org. Synth., 2015, vol. 92, p. 171. https://doi.org/10.15227/orgsyn.092.0171
El-Faham, A., Org. Prep. Proced. Int., 1998, vol. 30, pp. 477–481. https://doi.org/10.1080/00304949809355316
Bazhenov, M.A., Shernyukov, A.V., Kupryushkin, M.S., and Pyshnyi, D.V., Russ. J. Bioorg. Chem., 2019, vol. 45, pp. 699–708. https://doi.org/10.1134/S1068162019060074
ACKNOWLEDGMENTS
We would like to thank the Joint Center for Collective Use of the Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, for the mass spectroscopic analysis of the oligonucleotides and A.S. Chubarov (junior research worker of the Biomedical Chemistry Laboratory of the Institute of Chemical Biology and Fundamental Medicine) for recording the NMR spectra.
Funding
This study was supported by the base budgetary financing of the Program of the Basic Scientific Research of the State Scientific Academies in 2013–2020, projects nos. АААА-А17-117020210024-8. M.S. Kupryushkin thanks the Russian Scientific Foundation (project no. 19-14-00204) for the support of the synthesis and characterization of the native and modified oligonucleotides.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
COMPLIANCE WITH ETHICAL STANDARDS
This article does not contain any studies involving human participants and animals performed by any of the authors.
Conflict of Interests
M.S. Kupryushkin and D.V. Pyshnyi are cofounders of OOO NooGen. This company develops the technology for the preparation of phosphoryl guanidine oligonucleotides and their application. S.A. Zhukov declares that he has no conflicts of interest.
Additional information
Translated by L. Onoprienko
Abbreviations: ADMP, hexafluorophosphate of 2-azido-1,3-dimethylimidazolinium; CPG, controlled-pore glass; DIPEA, N,N-diisopropylethylamine; NA, nucleic acid; rpHPLC, reversed-phase high performance liquid chromatography.
Corresponding author: phone: +7 (923) 243-26-23.
Rights and permissions
About this article
Cite this article
Zhukov, S.A., Pyshnyi, D.V. & Kupryushkin, M.S. Synthesis of Novel Representatives of Phosphoryl Guanidine Oligonucleotides. Russ J Bioorg Chem 47, 380–389 (2021). https://doi.org/10.1134/S1068162021020291
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1068162021020291